Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-09-24
1977-10-04
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 31505
Patent
active
040525074
ABSTRACT:
A series of novel 1-piperidinesulfonylurea compounds derived from a pyrimidine monocarboxylic acid have been prepared by reacting an appropriate sulfamide with an organic isocyanate or a trisubstituted urea equivalent thereof. The sulfamylureas so obtained are useful in therapy as oral hypoglycemic agents. Typical members include those compounds derived from 1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione-5-carboxylic acid, of which 1-(bicyclo[2.2.1]hept-5-en-2-yl-endo-methyl)-3-{4-[2-(1,3-dimethyl-1,2,3,4 -tetrahydropyrimidine-2,4-dione-5-carboxamido)ethyl]-1-piperidinesulfonyl}u rea is a most preferred embodiment.
REFERENCES:
patent: 3705899 (1972-12-01), Regniev et al.
Goldberg Jerome D.
Pfizer Inc.
LandOfFree
Piperidinesulfonylurea derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidinesulfonylurea derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidinesulfonylurea derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1775503